-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
ATAI Life Sciences N.V. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- ATAI Life Sciences N.V. Operating Income (Loss) for the quarter ending September 30, 2024 was -$22.6M, a 15.8% increase year-over-year.
- ATAI Life Sciences N.V. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$106M, a 18.1% increase year-over-year.
- ATAI Life Sciences N.V. annual Operating Income (Loss) for 2023 was -$125M, a 13.3% increase from 2022.
- ATAI Life Sciences N.V. annual Operating Income (Loss) for 2022 was -$145M, a 6.61% decline from 2021.
- ATAI Life Sciences N.V. annual Operating Income (Loss) for 2021 was -$136M, a 30.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)